Diferencia entre revisiones de «Template:CMV retinitis treatment»
(Prepared the page for translation) |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
<languages/> | <noinclude><languages/></noinclude> | ||
<translate> | <translate> | ||
Revisión del 06:45 26 ene 2026
Severe Vision Threatening
- Ganciclovir intraocular implant for 8 months AND
- Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days
Peripheral lesions
- Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days
